Trinity Biotech (TRIB) Amortization of Goodwill (2021 - 2024)

Trinity Biotech has disclosed Amortization of Goodwill across 4 years of filings, most recently posting $962000.0 for Q4 2024.

• Amortization of Goodwill for Q4 2024 came in at $962000.0, up 231.72% year-over-year; the trailing twelve-month figure through Dec 2024 was $4.3 million (up 2.05% YoY), and the FY2024 annual result was $1.4 million, down 87.32% from the prior year.
• Amortization of Goodwill came in at $962000.0 for Q4 2024 at Trinity Biotech, up from $290000.0 in the prior quarter.
• In the past five years, Amortization of Goodwill ranged from a high of $3.0 million in Q4 2022 to a low of $519.0 in Q2 2022.
• The 4-year median for Amortization of Goodwill is $583000.0 (2021), against an average of $861097.8.
• Peak annual rise in Amortization of Goodwill reached 246.12% in 2022, while the deepest fall reached 91.45% in 2022.
• Trinity Biotech's Amortization of Goodwill stood at $876000.0 in 2021, then soared by 246.12% to $3.0 million in 2022, then slumped by 90.44% to $290000.0 in 2023, then jumped by 231.72% to $962000.0 in 2024.
• The last three Amortization of Goodwill figures came in at $962000.0 (Q4 2024), $290000.0 (Q4 2023), and $3.0 million (Q4 2022), per Business Quant data.